1. Home
  2. PAHC vs DRTS Comparison

PAHC vs DRTS Comparison

Compare PAHC & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Phibro Animal Health Corporation

PAHC

Phibro Animal Health Corporation

HOLD

Current Price

$37.88

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Logo Alpha Tau Medical Ltd.

DRTS

Alpha Tau Medical Ltd.

HOLD

Current Price

$14.27

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAHC
DRTS
Founded
1946
2015
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.4B
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
PAHC
DRTS
Price
$37.88
$14.27
Analyst Decision
Hold
Buy
Analyst Count
4
5
Target Price
★ $44.00
$17.80
AVG Volume (30 Days)
192.2K
★ 437.4K
Earning Date
11-04-2026
11-19-2026
Dividend Yield
★ 1.31%
N/A
EPS Growth
★ 104.20
N/A
EPS
★ 2.43
N/A
Revenue
★ $833,350,000.00
N/A
Revenue This Year
$3.83
N/A
Revenue Next Year
$3.49
$1,235.59
P/E Ratio
$15.06
★ N/A
Revenue Growth
★ 4.12
N/A
52 Week Low
$28.25
$3.43
52 Week High
$60.08
$15.79

Technical Indicators

Market Signals
Indicator
PAHC
DRTS
Relative Strength Index (RSI) 61.25 46.09
Support Level $36.47 $13.73
Resistance Level $37.92 $15.01
Average True Range (ATR) 1.27 0.57
MACD 0.27 -0.12
Stochastic Oscillator 92.90 11.24

Price Performance

Historical Comparison
PAHC
DRTS

About PAHC Phibro Animal Health Corporation

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.

Share on Social Networks: